AI assistant
El.En. — Investor Presentation 2020
Jan 27, 2020
4393_cp_2020-01-27_d79d501e-77c6-47d8-a09b-88193d7a5d5e.pdf
Investor Presentation
Open in viewerOpens in your device viewer
COMPANY PRESENTATION
Frankfurt - January 28th , 2020
Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.
AGENDA
1.El.En.
- 2.Markets and Growth drivers
- 3.Our Products
- 4.Financial Highlights
- 5.Latest News
- 6.Multiples & Comparables
El.En.
A Primary Player Providing Medical, Industrial and Conservation Laser Solutions Worldwide
Hi-Tech company
Hi-Tech industrial group active in opto-electronics with proprietary technologies and know how developed over 35 years
Listed on the Milan Stock Exchange Star segment since 2000
Global Group
More than 20 companies active worldwide on several laser application segments and markets
Among the leaders in its space with a Worldwide distribution network
Progressively widening its worldwide presence registering continuous growth over the years More than 45,000 laser sources sold and 5% of revenue invested in R&DMore than 120 patents
More than 90 R&D specialists
El.En. Worldwide
Long term market trends
Aesthetics:
- Aging population
- Growing global obesity epidemic
- Increasing desire of many individuals to improve their appearance
- Reduction in procedure costs, attracting a broader consumer base
9
Minimally invasive surgeries:
- Minimally painful procedures
- Reduced side effects and risks
- Hospitalization days reduction
- Savings by Private & National Health Systems
- ROI increase for surgical services providers
Long term market trends
Laser cutting applications:
- Enhanced flexibility, productivity and quality standards in manufacturing processes
- New application verticals
- Building and construction
- Minimal environmental impact
Laser marking:
- Products identification and traceability
- Minimal environmental impact
Medical & Aesthetic energy-based systems market
| \$ i l l i U S m o n |
2 0 1 4 |
2 0 1 6 |
2 0 2 1 |
C A G R 1 1 6 4- |
C A G R 1 6- 2 1 |
|---|---|---|---|---|---|
| l b l d l l G i i i i o a n o n- n v a s v e a n m n m a |
|||||
| y d l h i i i i t t t t t n a s e m e c a a e s e c r e a m e n v v |
|||||
| t s y s e m s |
6. 9 3 2 |
8. 4 3 7 |
1 3. 9 9 2 |
1 0 % |
1 1 % |
| b d E t t t t n e r g y a s e r e a m e n s y s e m s - |
2. 0 3 3 |
2. 6 7 0 |
4. 3 8 0 |
% 1 5 |
% 1 0 |
| d h k h B i & S i i i t t o y s a p n g n g e n n g |
7 2 4 |
9 9 6 |
1. 9 6 5 |
1 7 % |
1 5 % |
| k S i j i t n r e u v e n a o n |
5 2 3 |
6 9 5 |
1. 0 8 9 |
% 1 5 |
% 9 |
| l i H a r r e m o v a |
3 3 5 |
3 1 4 |
3 3 3 |
-2 % |
0 % |
| i L t t t e g v e n r e a m e n s |
1 3 1 |
1 5 7 |
1 8 7 |
% 9 |
% 4 |
| d A i t c n e r e u c o n |
9 6 |
1 1 0 |
1 2 5 |
% 7 |
3 % |
| l V i j i t a g n a r e u v e n a o n |
n a |
1 0 5 |
3 3 2 |
n a |
2 6 % |
| d l l i i & P t t t t g m e n e e s o n a o o r e m o a v |
8 0 |
9 9 |
1 4 2 |
% 1 1 |
% 7 |
| h O t e r |
1 2 6 |
1 6 7 |
2 0 7 |
1 5 % |
4 % |
| l T t o a |
2. 0 3 3 |
2. 6 0 7 |
3 8 0 4. |
% 1 5 |
0 % 1 |
Source: Medical Insight Report
Key growth drivers:
- Increasingly aging population
- Desire to achieve or maintain youthful appearance
- Increase in healthcare spending
- Requirements for fast and minimally invasive surgical procedures
Reports n Reports' analysts forecast :Medical aesthetics market
2018 to 202310.6% CAGR
11
Industrial laser market
Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity
- •Sheet metal cutting: technology breakthroughs leading to strong demand expansion
- •Laser marking for identification: traceability as a quality standard
MARKET STUDIES:
Technavio's analysts forecast :
"The global industrial laser market to grow at a CAGR of 10.24% during the period 2017-2021"
Growthdrivers
MEDICAL
- Stronger presence in body contouring and cellulite treatment market
- New laser systems for hair removal
- Novel dermatologic treatment device
- OEM urology partnerships
- New products pipeline
INDUSTRIAL
- New manufacturing applications for medium power CO2laser sources
- Strong demand for high power laser sheet metal cutting systems in China and Europe
- Strong manufacturing presence in China
Our critical success factors
- -Continuous innovation (breakthrough products)
- -Flexibility and improvement of production capacity (new factories)
- -Seeking regulatory clearances worldwide
Permanent Hair Reduction Highlights
QUANTA - THUNDER MT (Blended Alexandrite + Yag) –High end system. The fastest in the world with scanner technology
DEKA - MOTUS AX and MOTUS AY – Moveo Technology , virtually pain free also on dark skin types
ASCLEPION - NEW MEDIOSTAR with MONOLITH Handpiece 5kW diode -10 cm2 - 20 Hz
Vascular treatmentsHighlights
ASCLEPION – QuadroStarPRO YELLOW – 577 nm
QUANTA SYSTEM– 585and DenaVE (US Version) – 585 nm
Rembrandt's Syndrome
Tattoo and Benign Pigmented Lesions treatmentsHighlights
QUANTA SYSTEM – DISCOVERY PICO PLUS & Q-PLUS C MT (blended)
Almost 2 GW peak power (Pico)
BODY CONTOURINGHighlights
DEKA - ONDA COOLWAVES – the first system in the world based on Microwaves @ 2,5 GHz for localized fat accumulations, laxity, and cellulite reduction
MULTI PLATFORM TECHNOLOGYHighlights
DEKA – LUXEA – CE 0123 marked in 2019 by TUV Sud
The most complete multiplatform with
- •Diode laser handpiece for permanent hair reduction
- •IPL sets for skin tightening, skin rejuvenation, deeper vascular treatments and acne treatments
- •Active Q-switch probe for tattoo removal and pigmented lesions treatments
- •Nd:YAG 1064 nm probe for vessels treatments
- •Radio Frequency (RF) probe for skin rejuvenation and tightening
- •Er:YAG probe for micro ablative skin resurfacing
- Nd:YAP probe for non ablative skin rejuvenation
Total :15 different handpieces
•
PHYSIOTHERAPYHighlights
ASA LASER – M6 the only robotized system for pain removal
The multitarget Laser system created to apply MLS® Laser Therapy automatically and uniformly to the treatment area.
ASA LASER – HIRO TT
TT® is the ultimate application of Hilterapia®, creating new and innovative capabilities in the treatment of painful pathologies of the musculoskeletal system.
VAGINAL ATROPHY AND VAGINAL LAXITYHighlights
DEKA – MONA LISA TOUCH (MLT) WITH RF TOUCH
The most complete vaginal surgical multiplatform with:
- •CO2
- •New single use probes for MLT
- • New single use applicators for Treatment of vaginal laxity (non-surgical vaginal tightening) and vulvar treatment, in particular labia Majora and Minora hypertrophy. Adjuvant in the treatment of disorders of lower urinary tract: mild SUI (Stress Urinary Incontinence) and related symptoms.
Single use RF Touch Probe
UROLOGY - Stones Management and BPHHighlights
QUANTA SYSTEM– Litho 35 W Holmium laser QUANTA SYSTEM – Cyber Ho 60 W Holmium laser QUANTA SYSTEM – Cyber Ho 100 W Holmium laser ASCLEPION / JENA SURGICAL MultiPulse HoPLUS 140 W Holmium laser
with integrated morcellator
35 W60 & 100 W140 W2018 vs 2017 : +51,6% 23
UROLOGY – Virtual Stone Basket
QUANTA – Virtual Stone Basket Effect – onboard of 100 W Holmium lasers to avoid stone retropulsionand to capture stone fragments
PENTA & PENTA CHUTIAN
•Automatic CNC machines with up to 20 kW fiber lasers onboard
BEVELING CUT our new laser special preparation for butt-welding metal sheet edges
Financial Highlights
IncomeStatement 9M-2019
| '0 E 0 0 u r o |
/ / 3 0 0 9 1 8 |
% | / / 3 0 0 9 1 9 |
% | % V a r. |
|---|---|---|---|---|---|
| d d i t u n a u e |
d d i t u n a u e |
||||
| d l M i e c a |
1 3 8 8 3 7 |
% 5 7 0 , |
1 7 0 7 6 1 |
% 6 0 4 , |
% 2 3 0 , |
| d l I i t n s r a u |
1 0 4 6 0 0 |
4 3 0 % , |
1 1 2 1 8 7 |
3 9 6 % , |
7 3 % , |
| l T R t o a e e n e s v u |
2 4 3 4 3 7 |
1 0 0 0 % , |
2 8 2 9 4 8 |
1 0 0 0 % , |
1 6 2 % , |
| G i r o s s m a r g n |
9 6 3 0 6 |
3 9 6 % , |
1 1 1 1 4 5 |
3 9 3 % , |
1 4 % 5 , |
| E B I T D A |
2 0 3 6 4 |
9 9 % , |
3 2 6 1 6 |
1 1 % 5 , |
3 % 5 7 , |
| E B I T |
2 0 0 0 7 |
8 2 % , |
2 6 4 4 5 |
9 3 % , |
3 2 2 % , |
| P I t r e a x n c o m e |
9 9 0 8 1 |
8 2 % , |
2 6 2 7 1 |
9 8 % , |
3 8 % 7 , |
| / / 3 1 1 2 1 8 |
/ / 3 0 0 9 1 9 |
||||
| d d i t u n a u e |
|||||
| f l i i i i N t t e n a n c a p o s o n |
6 2 6 4 1 |
0 8 9 5 1 |
|||
| 2 7 |
Revenue breakdown by business
Revenue breakdown by area
New factories
Jena - Asclepion
Vicenza – ASA Laser
Wenzhou (2nd) – Penta Laser
| l l Eu i io ro m n |
|||||||
|---|---|---|---|---|---|---|---|
| l C a p e p a n x |
2 0 1 8 |
d 2 0 1 9 t |
l T t o a |
||||
| l T t o a c a p e x |
2 7 |
1 2 |
3 9 |
||||
| f w h h: ic o l N t e w p a n s |
2 2 |
8 | 3 0 |
||||
| 3 | 1 |
Revenue and EBIT% guidance
Minorities acquisition in China
Acquired 45% of Penta Chutian Wuhan and 29,7% of Penta Laser Wenzhoufor approx. 20 mln euros + 5 mln of euros Earn Out .
34Transaction funded with available cashNo impact on financial consolidation and guidance
Minorities acquisition in China - Ratios
| l i E t q a e u y v u |
5 2 1 8 8 6 |
b '0 R 0 0 m |
|---|---|---|
| / / ( ) l f f i 3 0 9 2 0 9 E N F P 1 t n e r p r s e a e r e a s o v u |
4 6 7 8 7 5 |
b '0 R 0 0 m |
| l ( f h ) i i i i E W t t t n e r p r s e v a u e a e r u a n a c q u s o n |
5 0 8 8 7 5 |
b '0 R 0 0 m |
| 2 0 1 8 |
2 0 1 7 |
/ 9 2 0 1 9 |
|
|---|---|---|---|
| / l E V S a e s |
0 7 1 , |
0 7 9 , |
0 7 2 , |
| / V I A E E B T D |
1 6 7 , |
6 9 3 , |
1 1 8 8 , |
| / E V E B I T |
8 5 3 , |
8 3 2 , |
1 8 0 1 , |
| / P E |
9 9 9 , |
1 0 8 9 , |
1 9 2 5 , |
Elesta preliminary activities for IPO
- •50% currently owned – Net worth consolidation
- •2018 Revenue: €3 mln; 2018 Net Income: € 0,2 mln
- •Possible timing: first half 2020
Multiples
| / l l i i i F t t t n a n c a n v e s m e n s m e r m i l V E t n e r p r s e a e u |
@ 1 2 4 , 6 6 5 7 |
/ / 3 0 0 9 1 9 |
|
|---|---|---|---|
| f l i i i i N t t e n a n c a p o s o n |
0 8 @ 5 , |
/ / 3 0 0 9 9 1 |
|
| l. k E E M C t n a r e a p |
6 3 9 8 @ , |
3 3 0 0 € , |
|
| / ( ) l l S 8 % S E V 5 a e s a e s |
8 1 , |
||
| / ( ) E V E B I T 8 5 % E B I T |
1 9 2 , |
||
| / k l d i j. P B V A r c e o o a e u |
2 9 , |
||
| k h l d 's h i S E t t o c o e r q u y p e r s a r e |
1 1 5 , |
Comparables
| Am ou |
in m ln nts |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Se 3 0 h, 2 0 9 1 t. t p / d l he M ica Ae ic t t e s |
Pr ice |
Re ve nu e |
Va % r. Re v. |
E B I T |
E B I T % |
M K. Ca p. |
E V |
/ le E V Sa s ( *) |
/ E V E B I T ( *) |
/ k P Bo o lu Va e |
| Cu te ra |
\$ 3 1, 0 4 |
\$ 1 3 0 |
1 1 % |
\$ ( ) 1 0 |
-8 % |
\$ 4 4 1 |
\$ 4 2 0 |
2, 4 |
n. a. |
1 0, 0 |
| de In M o |
\$ 6, 9 9 4 |
\$ 0 9 1 |
3 % 5 |
\$ 2 4 |
3 8 % |
\$ 0 0 1. 5 |
\$ 3 3 1. 4 |
9, 1 |
2 0 4, |
9, 3 |
| Ve nu s |
\$ 5, 7 1 |
\$ 2 1 |
-2 % 4 |
\$ ( ) 2 2 |
8 8 % -1 |
\$ 6 9 1 |
\$ 8 1 5 |
9 1 1, |
n. a. |
n. a. |
| d l S isr M ica am e |
\$ 0, 5 1 |
\$ 8 5 |
9 % |
\$ 1 6 |
1 8 % |
\$ 2 2 7 |
\$ 1 2 5 |
0, 7 |
4, 0 |
0, 7 |
| ic Lu tr on |
€ 6, 2 2 |
€ 6 2 |
2 9 % |
-€ 8 |
3 % -1 |
€ 6 1 5 |
€ 6 1 4 |
8 1, |
n. a. |
8 1, |
| du ia l In tr s |
||||||||||
| ho ics I P G P Co to n |
\$ 1 4 4, 8 5 |
\$ 1. 0 0 8 |
-1 1 % |
\$ 2 3 4 |
2 3 % |
\$ 7. 6 9 0 |
\$ 6. 6 1 5 |
4, 9 |
2 1, 2 |
3, 2 |
| im du ie Pr In tr a s |
€ 2 1 7, 1 |
€ 3 0 7 |
% -4 |
€ 1 1 |
3 % |
€ 9 1 7 |
€ 3 2 1 |
0, 8 |
2 2, 4 |
1, 1 |
| 's Ha La n se r |
¥ 4 5, 4 5 |
6. 8 8 0 ¥ |
-2 % 1 |
3 8 ¥ 5 |
% 5 |
8. 0 0 ¥ 4 5 |
0. 3 ¥ 5 1 4 |
5, 5 |
0 0 1 5, |
6 5, |
| ( ) l. E En 1 |
€ 3 3, 0 0 |
€ 2 8 3 |
1 6 % |
€ 2 6 |
9 % |
€ 6 4 0 |
€ 5 7 7 |
1, 8 |
1 9, 2 |
2, 9 |
(1) EV and multiplies as for previous slide
(*) Revenue,Ebit and earnings annualized
39
best is yet to come…."
Nobel Prize for PhysicsProf. Gérard Mourou
El.En. S.P.A.
Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]
POLYTEMS HIR
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI [email protected] MARONGIU [email protected]. +39 06-69923324
Contacts